These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39239109)

  • 1. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling.
    Zhang C; Yang J; Chen S; Sun L; Li K; Lai G; Peng B; Zhong X; Xie B
    EPMA J; 2024 Sep; 15(3):525-544. PubMed ID: 39239109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
    Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
    EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
    Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
    EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
    Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
    EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine.
    Bi Q; Wu JY; Qiu XM; Li YQ; Yan YY; Sun ZJ; Wang W
    EPMA J; 2023 Jun; 14(2):307-328. PubMed ID: 37275548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
    Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
    EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
    Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G
    EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine.
    Hu D; Shen X; Gao P; Mao T; Chen Y; Li X; Shen W; Zhuang Y; Ding J
    EPMA J; 2024 Jun; 15(2):321-343. PubMed ID: 38841626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting acupuncture efficacy for functional dyspepsia based on routine clinical features: a machine learning study in the framework of predictive, preventive, and personalized medicine.
    Yin T; Zheng H; Ma T; Tian X; Xu J; Li Y; Lan L; Liu M; Sun R; Tang Y; Liang F; Zeng F
    EPMA J; 2022 Mar; 13(1):137-147. PubMed ID: 35273662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
    Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
    EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
    Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
    EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics and immune cells' profiling of COVID-19 patients for ICU admission prediction: in silico analysis and an integrated machine learning-based approach in the framework of Predictive, Preventive, and Personalized Medicine.
    Zhu K; Chen Z; Xiao Y; Lai D; Wang X; Fang X; Shu Q
    EPMA J; 2023 Mar; 14(1):101-117. PubMed ID: 36845281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
    EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
    Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
    EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Region of Portugal.
    Regateiro FJ; Silva H; Lemos MC; Moura G; Torres P; Pereira AD; Dias L; Ferreira PL; Amaral S; Santos MAS
    EPMA J; 2024 Mar; 15(1):135-148. PubMed ID: 38463621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine.
    Kim BR; Yoo TK; Kim HK; Ryu IH; Kim JK; Lee IS; Kim JS; Shin DH; Kim YS; Kim BT
    EPMA J; 2022 Sep; 13(3):367-382. PubMed ID: 36061832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.